Treatment for paediatric low cardiac output syndrome: Results from the European EuLoCOS-Paed survey

Archives of Disease in Childhood

Volumn 96, Issue 12, 2011, Pages 1180-1186

  Vogt, Winnie ^a   Läer, Stephanie ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; ILOPROST; LEVOSIMENDAN; MILRINONE; NITRIC OXIDE; NORADRENALIN; PROSTACYCLIN; TOLAZOLINE;

ARTICLE; CONTROLLED STUDY; EUROPE; FORWARD HEART FAILURE; HUMAN; OPEN HEART SURGERY; PRIORITY JOURNAL; QUESTIONNAIRE; SYSTEMIC VASCULAR RESISTANCE;

ALGORITHMS; CARDIAC OUTPUT, LOW; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; CHILD; DOBUTAMINE; DOPAMINE; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; EPINEPHRINE; EUROPE; HEALTH CARE SURVEYS; HUMANS; MILRINONE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; VASCULAR RESISTANCE;

EID: 81255199193     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-300370     Document Type: Article

References (41)

1. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003;107:996-1002. (Pubitemid 36258723)
2. Shi S, Zhao Z, Liu X, et al. Perioperative risk factors for prolonged mechanical ventilation following cardiac surgery in neonates and young infants. Chest 2008;134:768-74.
3. Ma M, Gauvreau K, Allan CK, et al. Causes of death after congenital heart surgery. Ann Thorac Surg 2007;83:1438-45. (Pubitemid 46440755)
4. Roth SJ, Adatia I, Pearson GD. Summary proceedings from the cardiology group on postoperative cardiac dysfunction. Pediatrics 2006;117:S40-6. (Pubitemid 46063171)
5. Brierley J, Carcillo JA, Choong K, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 2009;37:666-88.
6. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
7. Yoon EY, Davis MM, El-Essawi H, et al. FDA labeling status of pediatric medications. Clin Pediatr (Phila) 2006;45:75-7. (Pubitemid 43362661)
8. European Medicines Agency. Assessment of the Paediatric Needs - Cardiovascular Products. 2006. http://www.ema.europa.eu/docs/en-GB/document- library/Other/2009/10/WC500004057.pdf (accessed 21 April 2011).
9. Pasquali SK, Hall M, Li JS, et al. Corticosteroids and outcome in children undergoing congenital heart surgery: analysis of the Pediatric Health Information Systems database. Circulation 2010;122:2123-30.
10. Turner S, Nunn AJ, Fielding K, et al. Adverse drug reactions to unlicensed and offlabel drugs on paediatric wards: a prospective study. Acta Paediatr 1999;88:965-8. (Pubitemid 29448261)
11. Maltz LA, Klugman D, Wessel DL. Off-label drug use in a single center pediatric cardiac intensive care unit. Presented at the American Academy of Pediatrics (AAP) National Conference and Exhibition, 17-20 October 2009, Washington, DC.
12. Vogt W, Läer S. Drug use patterns for the prevention of paediatric low cardiac output syndrome in Europe. Intensive Care Med 2011;37:1390-1.
13. Vogt W, Läer S. Prevention for paediatric low cardiac output syndrome: results from the European survey EuLoCOS-Paed. Pediatr Anesth 2011;(In Press) doi: 10.1111/j.1460-9592.2011.03683.x.
14. Oldner A, Rossi P, Karason S, et al. A practice survey on vasopressor and inotropic drug therapy in Scandinavian intensive care units. Acta Anaesthesiol Scand 2003;47:693-701. (Pubitemid 36760699)
15. Leone M, Vallet B, Teboul JL, et al. Survey of the use of catecholamines by French physicians. Intensive Care Med 2004;30:984-8. (Pubitemid 38639497)
16. Kastrup M, Markewitz A, Spies C, et al. Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: results from a postal survey. Acta Anaesthesiol Scand 2007;51:347-58.
17. Baño Rodrigo A, Domínguez Pérez F, Fernández Pineda L, et al. [Practice Guidelines of the Spanish Society of Cardiology in the postoperative course of congenital heart diseases]. Rev Esp Cardiol 2000;53:1496-526.
18. Carl M, Alms A, Braun J, et al. [Guidelines for intensive care in cardiac surgery patients: haemodynamic monitoring and cardio-circulatory treatment guidelines of the German Society for Thoracic and Cardiovascular Surgery and the German Society of Anaesthesiology and Intensive Care Medicine]. Thorac Cardiovasc Surg 2007;55:130-48.
19. Dillman DA. Mail and Internet Surveys: The Tailord Design Method. 2nd edition. Hoboken, NJ: John Wiley & Sons 2007.
20. Lumsden J. Guidelines for the Design of Online Questionnaires: 1st Edition. Ottawa, ON: National Research Council Canada, 2005.
21. Presser S, Blair J. Survey pretesting: do different methods produce different results. Sociol Methodol 1994;24:73-104.
22. Burns KE, Duffett M, Kho ME, et al. A guide for the design and conduct of selfadministered surveys of clinicians. CMAJ 2008;179:245-52.
23. Carcillo JA, Piva JP, Thomas NJ, et al. Shock and shock syndromes. In: Slonim A, Pollack M, Bell MJ, Berger J, Carcillo JA, eds. Pediatric Critical Care Medicine. Philadelphia, PA: Lippincott Williams and Wilkins 2006:438-71.
24. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2011. 2011. http://www.whocc.no/ (accessed 18 April 2011).
25. Altman DG, Machin D, Bryant TN, et al. Statistics with Confidence. 2nd edition. Bristol: BMJ Books 2000.
26. Bergman U, Popa C, Tomson Y, et al. Drug utilization 90% - a simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998;54:113-8. (Pubitemid 28204263)
27. National Research Ethics Service. Defining Research. NRES Guidance to Help You Decide If Your Project Requires Review by a Research Ethics Committee 2009. http://www.nres.npsa.nhs.uk/applications/guidance/ (accessed 28 July 2010).
28. Barton P, Garcia J, Kouatli A, et al. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study. Chest 1996;109:1302-12. (Pubitemid 26145670)
29. Kwapisz MM, Neuhäuser C, Scholz S, et al. Hemodynamic effects of dobutamine and dopexamine after cardiopulmonary bypass in pediatric cardiac surgery. Paediatr Anaesth 2009;19:862-71.
30. Bohn DJ, Poirier CS, Edmonds JF, et al. Hemodynamic effects of dobutamine after cardiopulmonary bypass in children. Crit Care Med 1980;8:367-71.
31. Nieminen MS, Brutsaert D, Dickstein K, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 2006;27:2725-36. (Pubitemid 44729876)
32. Carl M, Alms A, Braun J, et al. S3 guidelines for intensive care in cardiac surgery patients: hemodynamic monitoring and cardiocirculary system. Ger Med Sci 2010;8:1-25.
33. Momeni M, Rubay J, Matta A, et al. Levosimendan in congenital cardiac surgery: a randomized, double-blind clinical trial. J Cardiothorac Vasc Anesth 2011;25:419-24.
34. European Medicines Agency. Revised Priority List for Studies into Off-Patent Paediatric Medicinal Products for the 5th Call 2011 of the 7th Framework Programme of the European Commission. Revision 2010. http://www.ema.europa. eu/docs/en-GB/document-library/Other/2009/10/WC500004017. pdf (accessed 28 July 2010).
35. National Institutes of Health. List of drugs for which pediatric studies are needed. Fed Regist 2003;68:2789-90.
36. O'Connor CM, Gattis WA, Uretsky BF, et al. Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1999;138:78-86. (Pubitemid 29331125)
37. Cuffe MS, Califf RM, Adams KF Jr, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287:1541-7. (Pubitemid 34269999)
38. Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996;24:1580-90.
39. Barrett JS, Narayan M, Patel D, et al. Prescribing habits and caregiver satisfaction with resources for dosing children: rationale for more informative dosing guidance. BMC Pediatr 2011;11:25.
40. Summary of Product Characteristics. Dobutamin Liquid Fresenius 250 mg/50 ml Infusionslösung. Revision May 2008. http://www.fachinfo.de (accessed 1 April 2011).
41. Adams AS, Soumerai SB, Lomas J, et al. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care 1999;11:187-92. (Pubitemid 29302446)